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The attempted synthesis of p-nitrobenzyloxycarbonyl-L
phenylalanyl-N-carbobenzoxy--L-histidyl~L- leucine methyl ester,
an intermediate in the synthesis of p-nitrobenzyloxycarbonyl-L
phenylalanyl_N_carbobenzoxy_L_histidyl_L_leucine_4_hydroxy3_
methoxybenzyl ester is described. This tripeptide intermediate
will be important in the development of a tripeptide fluorogenic
substrate for angiotensin-converting enzyme because of its fluore
scent probe.
Analyses indicate that L-phenylalanyl-N-carbobenzoxy-L
histidyl-L-leucine methyl ester hydrochloride tetrahydrate was
obtained as a result of cleavage of the p-nitrobenzyloxycarhonyl
group from p-nitrobenzyloxycarbonyl-L-phenylalanyl-N-carbohenzoxy
L-histidyl-L-leucinemethyl ester.
We attempted to prepare the tripeptide intermediate by the
use of the stepwise approach starting from the carboxyl terminal
end and adding one N-protected acid after the other. Dicarbobenzoxy
L—histidine and L-leucine methyl ester were coupled by the dicyclo—
hexylcarbodiimide method to form dicarbobenzoxy-L-histidyl-L
leucine methyl ester. The latter was treated with hydrobromic acid
in dioxane and the crude dihydrobromide, after neutralization, was




A subject of intense study in recent years has been the
angiotensin 1—angiotensin II system as it is involved in normal
homeostasis of blood pressure and in certain forms of hypertension.
Massive research efforts in the past few years have been applied
to estimate the degree of involvement of the angiotensin 1-angiotensin
II system in the development of chronic hypertension. The prevailing
evidence strongly suggests that the angiotensin system plays an
important role in the initial stages of development of hypertension.
Although the angiotensin system may be initially activated by certain
hormones, it is quite clear that angiotensin is not involved in
maintaining elevated pressure in chronic hypertension.
Hypertension affects almost one—third of the total population
of the United States yet assay procedures to detect other clinical
manifestations of this disease concentrate on methodology that
measures plasma renin activity primarily by radioimrnunoassay which
is specific but time-consuming, laborous and cannot be considered
as a routine clinical test. Therefore, the primary objective of
this and subsequent research at Atlanta University is to develop
a fluorescent spectrophotometric assay that is rapid and quantita
tive for the angiotensin-converting enzyme that is involved in the
conversion of angiotensin I to angiotensin II. The development of
this assay system will have clinical significance in quantitating
the converting enzyme in the conversion of angiotensin I substrate
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to ang:iotensin II during the development of hypertension in rats
and rabbits.
Angiotensin-I-converting enzyme is a halide-activated peptidase
that splits off hydrolytically the dipeptide Ilis-Leu from the
carboxyl end of the decapeptide angitensin 1, thereby converting it








In the past, only angiotensin I was used as the substrate in
assays for measuring the converting enzyme activity. But recently,
synthetic oligopeptide substrates have been developed for the con
verting enzyme. Also, there has been some success in working out an
assay for the converting enzyme activity, based on the synthetic
substrate.
The N-acryltripeptide, 2—aminobenzoylglycyl-p-nitrophenyla-
lanyiproline was synthesized and applied as a substrate in the assay
of angiotensin-I-converting enzyme from calf lung and human serum.
This compound belongs to a new class of substrates for proteolytic
enzymes, having the general structure F-X--Q in which fluorescence
of group F is quenched by intramolecular interaction with the group
3
Q. Enzymatic cleavage of the peptide chain (X stands for one or
more amino acid residues) generates the unquenched F-containing
derivatives and the resulting fluorescence is used for quantitative
measurement of the hydrolysis rate. Cleavage of the Gly-Phe (NO2)
peptide bond in the weakly fluorescent 2-aminobenzoylglycyl-p-
nitrophenylalanylproline molecule results in appearance of 71 times
higher fluorescence (Amax = 415) of 2-aminobenzoylglycine. Continu
ous recording of the rising fluorescence allows convenient, sensitive
and specific determination of the enzymatic activity.
In a recent study, Carmel and Yaron2 synthesized the internally
quenched fluorescent tripeptide derivative Abz_Gly_Phe(N02)_Pro* and
developed an assay for the converting enzyme activity, based on this
peptide as a substrate. The fluorescent aminobenzoyl (Abz) group
incorporated in this peptide, which can be excited in the 300-380 nm
range, is effectively quenched by the Phe(N02) residue. This
quenching mechanism is abolished upon cleavage of the peptide bond
Gly-Phe(NO2) and the fluorescence which develops is proportional
to the amount of the liberated Abz-Gly. This method is simple,
highly sensitive, enables continuous measurement of the hydrolysis
rate and is applicable to the assay of converting enzyme activity
present in relatively crude preparations from calf lung.
*~Abbreviations. Abz, 2-aminobenzoyl; Phe(N02), p-nitro-L
phenylalanine
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In our study, we attempted to synthesize p-nitrobenzyloxy
carbonyl-L-phenylal anyl-N-carbobenzoxy-L-histidyl—L- leucine methyl
ester [ (N02)Z-Phen-Z-I-Iis-Leu-OMe] .~ This compound will be used as
an intermediate for the synthesis of p-nitrobenzyloxycarhonyl-L
phenyialanyl-N-carbobenzoxy-L-histidyL-L-leucine-4-hydroxy-3-
methoxyhenzyl ester [(N02)Z-Phe—Z-———--His-—-Leu-OBzl in subsequent
research at Atlanta University.
(N02)Z—Phe-—Z—His--Leu—OBz will be tested as an effective
substrate for angiotensin I-converting enzyme. The assay will be
based upon relief of the internal quenching of the 4-hydroxy-3-
methoxybenzyl group fluorescence by the nitrobenzyl group
(N02)Z-Phe] •when the substrate is enzymatically hydrolyzed to
produce (N02)Z-Phe and Z-His-Leu-OBz.
The primary purpose of this research was to synthesize the
(N02)Z-Phe-Z—His-Leu-OMe tripeptide intermediate. The work described
in this study is concerned with certain methods and problems of
peptide synthesis and with the synthesis and characterization of
the tripeptide intermediate.
The basic problem of peptide synthesis is one of protecting
the amino group. In bringing about interaction between the car
boxyl group of one amino acid and the amino group of a different
amino acid, one must prevent interaction between the carboxyl group
*_....Abbreviations. (N02)Z, p-nitrobenzyloxycarbonyl; Z,
carboben zoxy
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and the amino group of the same amino acid. In preparing glycylala—
nine, for example, one must prevent the simultaneous formation of
glycyiglycine. Reaction can be forced to take place in the desired
way by attaching to one amino acid a group that renders the -NH2
unreactive. There are many such protecting groups; the problem is
to find one that can be removed later without subsequent destruction
of peptide bonds.
+ —
H3NCHCOO .—~--_~ Q—NHCHCOOH -) Q—NHCI-ICOC1
R R R
Protection of amino group
+
Q-NFIC[ICOC1 + H3NCHCOO ) Q-NIICHC-NHCHCOOH
R Pi RO
Foruation of peptide linkage
Q-NH-CHC-NHCHC000II ~ H3NCI-IC-NHCIICOO
H H
RO R’ RO R~
(Q = C6H~CO) Peptide
Removal of the protecting group
We could, for example, henzoylate glycine, convert this into the acid
chloride, allow the acid chloride to react with alanine, and thus
obtain benzoylglycylalanine. But if we attempted to remove the
benzoyl group by hydrolysis, we would simultaneously hydrolyze the
other amide linkage (the peptide linkage) and thus destroy the peptide
we were trying to prepare.
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Of the numerous methods developed to protect an amino group,
we shall look at just one: acylation by henzyl chiorocarbonate,
also called carbobenzoxy chloride. (This niethod was used in our
peptide synthesis.~ The reagent C6H5CH2OCOC1 i~ both an ester and
an acid chloride.
Like any acid chloride, the reagent can convert an amine into
an amide-type group, a urethane.
C5Ii’~CH2O=C—Cl + H2NR C61-15CH20—C—NHR
0 0
Amine A Urethane
The carbohenz.oxy group can be cleaved by reagents that do not disturb
peptide linkages: catalytic hydrogenation or hydrolysis with hydrogen
bromide in cold acetic acid or dioxane.
H2Pd C6H5CFI3 + 1H0-Cr-NIJR]) CO2 + RNH2
H
C6H5CH2O-C-NHR r A carbamic acid




Certain advantages are offered by the use of the stepwise approach
starting from the carboxyl terminal and adding one N-protected amino
acid after the other. The p-nitrophenyl ester method is applied
preferentially to this type of synthesis. Good results have also
been obtained with the carbodiimide method. The azide method is
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frequently used for the carbodiimide method as it is more easily
removed from the reaction product than is the case for two peptides
of practically identical chain length. It is worthy of note that
racemization generally does not occur when using the carbodiimide
method, and that crystalline products are obtained more frequently
than is the case otherwise. Some workers, however, may rate the more
extensive time requirements a disadvantage.~
It must he emphasized that it is impossible to generalize on
the advantages or disadvantages of individual synthetic principles,
coupling methods, or protection groups. The special problems
encountered, the wealth of experience accumulated by ind:ividual
research groups, and not least, the skills of those conducting the
syntheses are of eminent importance.
The synthesis of p-nitrobenzyloxycarbonyl-L-phenylalanyl-N
carbobenzoxy-L--histidyl--L-leucine methyl ester involves the following
stepwise reactions:
Step 1. Synthesis of L-Leucine Methyl Ester
0 0
H 1
(C113)2 C1-1--CH2--CI1-C-OH + ~(CH3)2CH-CFI2-CH-C-0C113
NFl2 NH2IICI.
(50% K2C03
(CII ~) 2~’~11 2—CIl—C—0C113
NH2
The carboxyl group of L-leucine is esterified when reacted with
8
methanol in the presence of dry hydrogen chloride. The carboxyl
group of L-leucine is protected and the amino group remains active
for peptide synthesis.




+ ~H~O~C ~CII2~h~COOH ~
Carbobenzoxy chloride is used to protect the amino group and the
imidazole group of L-histidine. The carboxyl group of L-histidine
remains active for peptide synthesis. The carbobenzoxy group linked
at the imidazole nitrogen of histidine is resistant to treatment
with hydrogen bromide in glacial acetic acid or in dioxane.
When the esters of N(a), N(im~ -dicarbobenzoxy—L--histidine
peptides are treated with hydrogen bromide in glacial acetic acid
or in dioxane, the action of the acid reagent leads to selective
decarbobenzoxylation at the a—position under the ordinary conditions.
The resulting N(Im)—carbobenzoxy-L-histidine derivatives can he
smoothly coupled with the carboxyl functions by the carbodiimide
method to give peptide bonds at the a-position of histidine (Step
5
3, 4 and 5)
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Step 3. Synthesis of N(Im)-Carbobenzoxy-L-Histidyl-L-Leucine
Me~thy1 Ester.
NH_L~’_OCH2_Q


















~~K2~3 H~ ~1-CH2 -CH-C-NH-CH-CH2 -CH(CH3)2
N~N~C_OCH2O C-OCI-13
The above reaction involves the fQrmation of a peptide linkage,
as a result of the interaction between the active carboxyl group
of histidine and the active amino group of leucine. The reactants
are coupled by the carbodiimide method. This sequence also involves
the selective decarbobenzoxylation at the a-position of histidine
due to treatment with hydrogen bromide in dioxane.
Step 4. Synthesis of p—Nit~obenzyloxycarbonyl-L-Phenyla1~n:ifle.
NFl2 0
~)_CI12_~H_C0OH + N02~H2-O-C-Cl~~ F:
NIl(~-OCH2~0~
1~~1CHC11CO0II
The p-nitrobenzoxy group is used to protect the amino group of
L-phenylalanine. The carboxyl group of L-phenylalanine remains active
for peptide synthesis. The p-nitrobenzoxy group is used as a
Ii
protecting group inst cad of the carhobcnzoxy group because of its
fluorescence quenching effect.
tep S. Svnthcs~sofp-Nitrobehzy~oxycarhonyLi ~-Mieny1a[any1-
N—Carbobcnzoxy—L--Histidyl —L—Leucinc Methyl Lster.
Nil2
—CII— ~—NH-CFI—Cll2 CII (CII3~J2
~-OCH~5 C-OCI 13
+
NI I-C-PCI 1~ NC
(:112-CII-cooIl
0
NIl- C- CII- CI J;j~ f ~
H
j[7~_~rr_(~li2__CII_ (:—Nll—(;F!—ClI~ —c:I1((:I1~ ) 2
N N-C-CX;Il~~
U 1 U ~
11j 0
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The final step in the synthesis of p-nitrobenzyloxycarbonyl
phenylalanyl-N-carbobenzoxyl-L-histidyl-L-leucine methyl ester
involves the interaction of the amino group of L-histidyl-L-leucine
dipeptidc with the carboxyl group of the phenylalanyl derivative in
formation of a peptide linkage. The reactants are smoothly coupled
by the carbocIi~mic1e method.
Again, it must be emphasized that the synthesis of (NO2)
Phe-Z-Flis-Leu-OMe is important because this tripeptide derivative
will be used as an intermediate in the synthesis of a fluorogenic
substrate for angiotensin-converting enzyme.
RESULTS AND DISCUSSION
We attempted to synthesize the tripeptide intermediate,
(NO2)Z-Phe-Z-His-Leu—OMe, by the use of the stepwise approach
described in the introduction of this paper.
However, according to the elemental analysis, the compound
observed was different from that expected. We interpreted the
elemental analysis as characteristic of a mixture containing 65%
of the tripeptide L-phenylalanyl-N-carbobenzoxy-L-histidyl-L-
leucine methyl ester hydrochloride tetrahydrate and 35% of the
starting material p—nitrobenzyioxycarbonyl-L-phenylalanine with
the following structures, respectively:
NH2 IIC1
I







The elemental analysis of the mixture calculated corresponds
very closely to that found (see Experimental).
The presence of the tripeptide in the mixture with the
above structure may he the result of cleaving the protective
group, p—nitrobenzyloxycarbonyl, from (N02)Z-Phe-Z--His-Leu-OMe by
acid hydrolysis. In preparing (N02)Z-Phe--Z-His-Leu-OMe (Step 5),
N,N’-dicyclohexylurea is separated from the product by extraction
with concentrated hydrochloric acid.
The decarbobenzoxylation by hydrochlo~ic acid has been investi
gated in great detail by several authors. White conducted the
cleavage under vigorous conditions, employing concentrated HC1 at
700.6 Currently, concentrated hydrochloric acid is used at 370 for
1-1.5 hours. Ester bonds present will be hydrolyzed. Therefore,
under certain conditions the simultaneous cleavage of the carbo
•benzoxy and p-nitrobenzyloxycarbonyl groups is possible.
The carhobenzoxy group linked at the i:miclazole nitrogen of
histidine is resistant to acid hydrolysis, Presumably the tripepticle,
(N02)Z—Phe-Z-His-Leu-OMe, reacted with the hydrochloric acid and gave
the corresponding tril)epetide derivative as the hydrochloride as
follows:
I
NFJ-C~ 0--Cl 12 ~~‘N02
NIi-C-C1i-Ci12—-r~~N NC I
I ~?







N N~-C--0Cli~( ~ -
~~-‘ 1 L~i
11 ()
The in Frared absorption ana.1 yscs Fu:rthe r confirmed the
prcscnc.c of the t.ripeptide di’ix’ative in the mixture. The ab—
sorpt ~ i~a~ at (. 0 am (1b70 cm ) (F ig. 1) .1s churacteri st i c
of the hydrochloride hand (C-Nil3 CI) in Phe-Z-iiis-icu-OMe 1IC.1.
The methyl ester group of the tripopti (IC shows a strong carbonyl
stretching hand at S. 8 1~rn (1720 cm 1) and two strong hands lo r the
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C-O stretching at 9.4 pm(1065 cm1), and 8 pm(1250 cmi).
The infrared spectrum also supports the presence of the
unreacted p-nitrobenzyloxycarbonyl-L-phenylalanine component
of the mixture. The absorption peaks at 7.4 pm(135O crn1), and
6.6 pm(1525 cm~) are characteristic of the symmetrical N02 and
asymmetrical NO2 stretch respectively. Furthermore, the band at
1410 cm-’ due to OH bending from the carboxyl group is diminished
from the tr;ipeptide spectrum hut the band is strongly absorbing
in the (N02)Z—Phe derivative spectrum (Fig. 2). This demonstrates
the formation of a peptide linkage between the carboxyl group
of the phenylalanyl derivative and amino group of L—histidyl-L
leucine dipeptide.
The mixture molecular weight was found to be 641. We
calculated the average molecular weight to be 561. The molecular
weight of Phe—Z-His-Leu-OMe • F1Cl~ 4H2O is 671, which corresponds
very closely to the molecular weight found for the mixture. However,
the difference between the molecular weight found for the mixture
and the average molecular weight calculated for the mixture may
possibly be due to the method used to determine the molecular
weight and impurities present in the mixture. Most methods used to
determine molecular weights are highly susceptible to error caused
by low-molecular weight impurities.
However, the impurities in the product could have been reduced

























Therefore, these results and observations have led us to
the conclusion that the product we obtained was a mixture of
65% tripeptide (Phe-Z-His-Leu-OMe HC1 4H20), and 35% starting
material [ (N02)Z-Phe—OH j , and not the tripeptide (N02)Z-Phe-Z-
FIis-Leu-OMe we attempted to prepare. Due to hydrolysis of the p—
nitrohenzyloxycarhonyl group from (N02)Z-Phe-Z-lIis-Leu-OMe, we can
not use the resulting tripeptide derivative as a probe to monitor
angiotensin-converting enzyme activity in a fluorescent spectro
photometric procedure.
At present the azide coupling method is being advanced as an
alternate approach for the synthesis of the tripeptide derivative.
EXPERIMENTAL
Synthesis of L-Leucine Methyl Ester llydrochloridé.---Dry
hydrogen chloride (about 25 g) was passed for 2 hrs with continuous
stirring into a mixture containing 62.5 g of purified L-leucine
suspended in 375 ml of absolute methanol. The solvent was removed
by rotary evaporation and the residual thick mass of crystals was
cooled to 0° and filtered. The crystals were dried in vacuo over
NaOH. The total yield of L-leucine methyl ester hydrochloride was
65 g (77%); m.p. 149-151° [lit.7 m.p. 147-148°, 75%] ir (KBr)
1745 cm1 (ester C=0).
Synthesis of Dicarbobenzoxy-L-Histidine.--To a solution of
8.58 g (0.04 mole) of L-histidine monohydrochloride monohydrate in
20 ml of 4 N sodium hydroxide were added 42.4 ml of 5% sodium
carbonate and 30 ml of dioxane. The solution was cooled in an ice =
bath and then treated with 14.35 g (0.084 mole) of benzyl chlorofor
mate and 21 ml of 4 N sodium hydroxide in 5 equal portions within
40 mm. The mixture was stirred for an additional 20 mm at 0°.
The sodium salt of the product often separated as a crystalline
precipitate. After about 100 ml of ethyl acetate had been added,
the reaction mixture was neutralized with 6 N hydrochloric acid.
The aqueous phase was extracted twice with ethyl actate. Dioxanc
was removed by rotary evaporation and the resulting syrup was re
dissolved in ethyl acetate. The solution was washed with water,
dried over sodium sulfate, and evaporated to about 20 ml at 30° by
20
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rotary evaporation. The solution was cooled below _300 in a Dry
Ice bath. Scratching while cooling in the Dry-Ice bath caused the t
product to separate in a crystalline state. After addition of 50
to 60 ml of anhydrous ether., the crystals were allowed to stand for
2 hrs in the Dry-Ice bath. The crystals were filtered, washed with
anhydrous ether, and dried; wt. 7.5 g (46%), m.p. 92-94° lit.8
wt. 12.78 g(76%), m.p. 87-90° ; i.r. (KBr) 3300 cm (N-H) and
1710 cm1 (urethane C~0). The product was soluble in ethyl acetate
and chloroform, slightly soluble in ether, and insoluble in
petroleum ether and water.
Synthesis of Dicarbobenzoxy-L-Histidyl-L-Leucine Methyl Ester.--
A suspension of 1.52 g (0.0042 mole) of L-leucine methyl ester
hydrochloride in 80 ml of ether was cooled in an ice-salt bath and
shaken vigorously with 24 ml of ice-cold 50% potassium carbonate.
The aqueous phase was once extracted with ether and the ether extracts
were combined and dried over sodium sulfate at 0°. After removal of
the solvent by rotary evaporation, the resulting oil of the free ester
was dissolved in 40 ml of methylene chloride. To this solution
were added 2.9 g (0.0034 mole) of dicarbobenzoxy-L-histidine and
1.44 g (0.0042 mole) of N,N’-dicyclohexylcarbodiimide. The mixture
was allowed to stand overnight at room temperature and then refrigerated.
The separated dicyclohexylurea was filtered off, and the filtrate was
washed with hydrochloric acid, water, ice-cold 5% sodium bicarbonate and
water successively, and dried over sodium sulfate. Concentration by
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rotary evaporation gave a clear syrup, which was then dissolved in
20 ml of ethyl acetate. Upon addition of 20 ml of ether the product
slowly separated in silky needles. After refrigeration overnight
the crystals were filtered off, washed with ether, and dried; wt.
1.9 g (50%), mOp. 103-105.5° [lit? wt. 3.4 g (90%), m.p. l02~
l03.5°j; i.r. (KBr) 3320 cm’ (2°-N-li), 2950 cm’ (C-H) and 1710
cm’ (ester C=O).
Synthesis of Carbobenzoxy-L-Histidyl-L-Leucine~iethy1 Ester
Dihydrobromide.--A mixture, of 1.6 g (0.003 mole) of dicarbobenzoxy
L-histidyl-L-leucinc methyl ester in 7 ml of 37.5% (w/w) hydrogen
bromide in dioxane was allowed to stand at room temperature for
30 mm. Upon the addition of 20 ml of anhydrous ether an oil was
deposited which soon solidified. The solvent was decanted and the
precipitate was freeze-dried by rotary evaporation. The precipitate
was washed with ether and freeze-dried once again; wL. 1.44 g (81%).
The ester hydrobromide was too hygroscopic to be analyzed.
Synthesis of p_Nitrobenzyioxy~rbony1-J~ lalan.--A 10 g
sample of L-phenylalanine was dissolved in 3() ml of 2 N sodium
hydroxide under ice-cooling and vigorous stirring and then treated
with 6 g of p-ni.trobenzylchloroformatc and 31 ml of 4 N sodium
hydroxide in 4 equal portions within 40 mm. The mixture was stirred
for an additional 20 mm at 0°. The sodium-salt of the product
often separated as a crystalline precipitate. After about 120 ml.
of ethyl acetate had been added, the reaction mixture was neutralized
with 12 ml of 2 N hydrochloric acid. The aqueous phase was extracted
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twice with ethyl acetate. The combined extracts were dried over
sodium sulfate (overnight). The solvent were removed by rotary
evaporation and the residual thick mass of crystals was dried; wt.
7.1 gin (76%), ni.p. l09_l110, i.r. (KBr) 1340 cm1(sym. NO2) and 1700
cm1(ester C~O).
Synthesis of p-Nitrobenzyloxycarbonyl-L-phenylalanyl-N
Carbobenzoxy—L-Histidyl-L-Leucine Methyl Ester.--To a solution of
3.5 g (0~006 mole) of carbobenzoxy-L-histidyl-L-leucine methyl ester
dihydrobromide in 60 ml of inethylene chloride was added 24 ml of
ice-cold 50% potassium carbonate solution (in water). The aqueous
phase was saturated with sodium chloride and extracted with 10 ml
portions of methylene chloride, After drying over sodium sulfate,
the extracts were combined and evaporated down to 20 ml by rotary
dvaporation. To this solution was added 1.72 g (0.005 mole) of
p-nitrobenzyloxycarbonyi-L-pheriylalanine and 1.03 g (0.005 mole)
of N,N’-dicyclohexylcarbodiimide. The mixture was allowed to stand
overnight at room temperature and then refrigerated. The separated
dicyclohexylurea was filtered off, and the filtrate was washed with
1 N hydrochloric acid, water, ice-cold 5% sodium bicarbonate and with
water, successively, and dried over sodium sulfate. Concentration
by rotary evaporation gave a clear syrup.
A crude product of tripeptide was prepared by cooling 1 g of
the syrup below -30° in a Dry-Ice bath. Scratching while cooling
in the Dry-Ice bath caused t~e product to form into crystals. After
addition of 20 to 30 ml of ether the crystals were filtered and
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washed with anhydrous ether; wt. 0443 g (45%) m.p. 117°;
i.r. (KBr) 1720 cm (ester C=0) and 1350 cm1 sym. NO2).
Anal. Calcd for C38H42N6010: C, 61.48; H, 5.66; N, 11.31: M.W. 742.4
Found: C, 55.82; H, 6.10; N, 9.27; M.W~, 641.
Anal. Calcd for 65% C30H37N506 . HC1 4H20 and 35% C17H1606N2:
C, 55.63; H, 6.09; N, 9.52
Found: C, 55.69; H, 6.10; N, 9.27
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